Lukoye, Deus;Gustavson, Gail;Namuwenge, Proscovia M. ;Muchuro, Simon;Birabwa, Estella;Dejene, Seyoum;Ssempiira, Julius;Kalamya, Julius N.;Baveewo, Steven;Ferroussier-Davis, Odile;Mills, Lisa A.;Dirlikov, Emilio;Nelson, Lisa J.;Turyahabwe, Stavia2025-09-122025-09-122023-02-15Lukoye D, Gustavson G, Namuwenge PM, Muchuro S, Birabwa E, Dejene S, et al. Tuberculosis Preventive Therapy among Persons Living with HIV, Uganda, 2016–2022. Emerg Infect Dis. 2023;29(3):609-613. https://doi.org/10.3201/eid2903.221353ISSN 1080-6040, 1080-6059EISSN 1080-6059https://nru.uncst.go.ug/handle/123456789/12054During October 2016-March 2022, Uganda increased tuberculosis (TB) preventive therapy coverage among persons living with HIV from 0.6% to 88.8%. TB notification rates increased from 881.1 to 972.5 per 100,000 persons living with HIV. Timely TB screening, diagnosis, and earlier treatment should remain high priorities for TB/HIV prevention programming. MEDLINEenArticle